Fouad Namouni, M.D., has been appointed Oncology Development Head, Bristol-Myers Squibb, responsible for leading a comprehensive development strategy for the company’s oncology pipeline from early development through commercialization. He will continue to report to Francis Cuss, MB Bchir, FRCP, executive vice president, chief scientific officer, and remain a member of the R&D Leadership Team. Most recently, Dr. Namouni served as head of Medical, leading the worldwide medical organization ...